Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 5Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unresectable Hepatocellular Carcinoma 1Stomatitis 1Respiratory Aspiration 1Recurrence 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Periodontitis 1Pain 1Ovariancancer 1Ovarian Neoplasms 1Non Small Cell Lung Caner 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Myasthenia Gravis 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Calculi 1Immune Checkpoint Inhibitor-Induced Dermatitis 1Head and Neck Neoplasms 1Febrile Neutropenia 1Fatigue 1Dupuytren Contracture 1Depression 1

Interventions

Nivolumab 6pembrolizumab 3Specimen Handling 3Ipilimumab 3relatlimab 2cemiplimab 2Melphalan 2Magnetic Resonance Spectroscopy 2Interleukin-2 2vedolizumab 1trametinib 1toripalimab 1sulforaphane 1gadopiclenol 1famitinib 1anlotinib 1X-Rays 1Watchful Waiting 1Ultraviolet Therapy 1Toll-Like Receptor 1 1Therapeutics 1Temozolomide 1Technetium 1Standard of Care 1Sentinel Lymph Node Biopsy 1SHR-1701 1Rehabilitation 1Phototherapy 1Photopheresis 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Melanoma × Therapeutics × Clear all
NCT07406724 2026-02-12

HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced Melanoma

Qingdao Sino-Cell Biomedicine Co., Ltd.

Phase 2 Not yet recruiting
90 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡